Participating Organization(s)	National Institutes of Health (NIH)
Components of Participating Organizations	National Institute of General Medical Sciences (NIGMS)
Funding Opportunity Title	Research to Understand and Inform Interventions that Promote the Research Careers of Students in Biomedical and Behavioral Sciences (R01)
Activity Code	R01 Research Project Grant
Announcement Type	Reissue of RFA-GM-11-004
Related Notices	July 17, 2012 - This RFA has been reissued as RFA-GM-13-009.
Funding Opportunity Announcement (FOA) Number	RFA-GM-12-002
Companion FOA	NoneNone
Number of Applications	Section III. 3. Additional Information on Eligibility.
Catalog of Federal Domestic Assistance (CFDA) Number(s)	93.859
FOA Purpose	This Funding Opportunity Announcement (FOA) issued by the National Institute of General Medical Sciences (NIGMS), National Institutes of Health (NIH) solicits applications that propose research designed to test assumptions and hypotheses regarding social and behavioral factors with the aim of advising and guiding the design of potential interventions intended to increase interest, motivation and preparedness for careers in biomedical and behavioral research. NIGMS is particularly interested in those interventions that are specifically designed to increase the number of students from underrepresented groups entering careers in these disciplines. The proposed research need not be restricted to underrepresented students. Comparative research that analyzes the experience of all groups in order to place that of underrepresented students in context and to learn whether and how interventions should be tailored to make more underrepresented students successful in biomedical careers may well be particularly illuminating and is, therefore, encouraged.

Posted Date	July 13, 2011
Open Date (Earliest Submission Date)	September 21, 2011
Letter of Intent Due Date	September 21, 2011
Application Due Date(s)	October 21, 2011, by 5:00 PM local time of applicant organization.
AIDS Application Due Date(s)	Not applicable
Scientific Merit Review	January 2012
Advisory Council Review	May 2012
Earliest Start Date(s)	July 2012
Expiration Date	October 22, 2011
Due Dates for E.O. 12372	Not Applicable

Required Application Instructions

It is critical that applicants follow the instructions in the SF 424 (R&R) Application Guide except where instructed to do otherwise (in this FOA or in a Notice from the NIH Guide for Grants and Contracts). Conformance to all requirements (both in the Application Guide and the FOA) is required and strictly enforced. Applicants must read and follow all application instructions in the Application Guide as well as any program-specific instructions noted in Section IV. When the program-specific instructions deviate from those in the Application Guide, follow the program-specific instructions. Applications that do not comply with these instructions may be delayed or not accepted for review.

Part 1. Overview Information
Part 2. Full Text of the Announcement
Section I. Funding Opportunity Description
Section II. Award Information
Section III. Eligibility Information
Section IV. Application and Submission Information
Section V. Application Review Information
Section VI. Award Administration Information
Section VII. Agency Contacts
Section VIII. Other Information

Although the National Institutes of Health (NIH), other agencies of the federal government and private foundations have established a variety of diversity programs over the past 35 years to develop research careers and improve participation for individuals from groups with low representation in the biomedical and behavioral sciences, there is strong evidence that diversity continues to be an important problem in the U.S. scientific workforce (see for example, National Research Council, 2010 Expanding Underrepresented Minority Participation: America's Science and Technology Talent at the Crossroads. Washington, DC; National Academy Press; National Research Council, 2000. Addressing the Nations Changing Needs for Biomedical and Behavioral Scientists. Washington, DC; National Academy Press; http://www.nsf.gov/statistics/showpub.cfm?TopID=2&SubID=27) and http://www.nsf.gov/statistics/indicators). These diversity programs generally support three main types of objectives: a) increasing the participant pool generally by stimulating students' interest at multiple stages, starting as early as middle school; b) strengthening the participant pool via acquisition of knowledge, academic enrichment and development of skills deemed important for success as a scientist; and c) retaining the participant pool via remediation, support services such as tutoring and financial aid, bridging programs, and activities designed to motivate students for careers in biomedical and behavioral research. The types of interventions supported by the various programs almost always include financial support and encouragement to underrepresented undergraduate and graduate students to participate in biomedical and behavioral research in a variety of academic institutions.

While these objectives and interventions are generally held to be necessary, the specifics of their implementation are often based on knowledge of others presumed best practices and/or implicit assumptions, such as: a) when students are provided the opportunity to engage in state-of-the-art biomedical and behavioral research, with appropriate facilities, support and mentorship, their appetite will be whetted to enter careers in such research; and b) once focused on research careers, they will show improvement in academic and other skills needed to successfully pursue a research career in these fields. These assumptions are consistent with the experience of many successful scientists and make intuitive sense, and many different programmatic interventions have evolved over the years. These include creation of institutional environments that aim to promote research among students and faculty, on- or off-campus summer research experiences, attendance at professional scientific conferences and research seminars or journal clubs, tutoring in "gate-keeper" courses (e.g., organic chemistry, calculus), subsidy of GRE preparatory courses, post-baccalaureate transitional research experiences, and individual research fellowships or training-grant support. To date, few interventions are based on theoretically grounded research. Similarly, the ideas underlying these interventions have generally not been synthesized or analyzed systematically. Neither have the interventions been subjected to rigorous research study. A notable exception is the Merit Workshop at the University of California, Berkeley, which grew out of Uri Treisman's observations of study behaviors among at-risk students that challenged prevailing assumptions (College Mathematics Journal 23: 362-372, 1992). Other relevant works in this field include a longitudinal study on factors that contributed to successful completion of Ph.D. degrees in science, technology, engineering, or mathematics (STEM) disciplines at the University of California (http://cshe.berkeley.edu/publications/docs/minority_phd_final_report.pdf); studies of the impact of undergraduate research on pursuing Ph.D. degrees in STEM (Science 316:548-549, 2007; CBE Life Sciences Education 7:394-409, 2008); interracial interactions on student-faculty relationships and intellectual self-concept (Journal of Higher Education 78: 249-281, 2007); work-group size and organizational climate on becoming a scientist (Journal of Higher Education 78:311-336, 2007); and identification of student characteristics that predict persistence into research training (CBE Life Sciences Education 6:316-331, 2007). Further research is needed to develop an empirical base of evidence for new interventions, and improve our understanding of the social and behavioral factors involved in the development of biomedical and behavioral researchers.

The purpose of this funding opportunity is to support research that will test assumptions and hypotheses regarding social and behavioral factors that might inform and guide potential interventions intended to increase interest, motivation and preparedness for careers in biomedical and behavioral research, with a particular interest in those interventions specifically designed to increase the number of students from underrepresented groups entering careers in these disciplines. While the expression careers in biomedical and behavioral research is intentionally general, it includes basic and/or clinical research in academic, governmental, and/or corporate environments. The term intervention includes both broad programs and the cumulative effects of multiple activities as well as more narrowly specified interventions, or specific activities within a larger program.

Applicants must state their specific aims, objectives, goals and, in particular, the expected generalizable knowledge to be revealed by their proposed research. Since the focus of this FOA is on students from groups underrepresented in biomedical and behavioral research careers, proposed research involving non-underrepresented students should be comparative, rather than addressing non-underrepresented students exclusively. Applicants must explicitly identify the assumptions underlying the research question(s) to be studied, social science theories to be studied, and/or hypothesis to be tested. Examples of some basic types of questions that might inform this purpose include but are not limited to:

• Individual Student Characteristics: Which characteristics of a student (e.g., skills, preparation, attitude, motivation, self-efficacy, values, and knowledge) are more determinative in career choice? Are some characteristics more subject to intervention than others? Teacher/Mentor Relationship: What is the nature of influence of teachers/mentors or other role models?
• Family and Environment: With respect to the decision to enter (or remain) in a research career, what is the influence of peers, family, community, economics and job market? How can these be distinguished, measured, linked to outcomes and productively modified?
• Institutional Factors: What is the influence of culture of scholarship among the faculty in motivating high career aspirations in students?
• Program-related: What are the specific or purposeful designs of research experiences that are more effective in promoting persistence toward research careers than others, especially among underrepresented students? What are the ways, if any, that diversity programs inadvertently feed into stereotyping, stereotype threat or other psychological negative reinforcers? In what ways does a purposefully constructed program that is inclusive of all groups of students have different effects in this regard?

We recognize that most of these questions and the underlying assumptions are complex in nature, and we expect that their study will require multidisciplinary approaches. Therefore, collaboration among natural, behavioral and social scientists, and other appropriate experts, is considered appropriate and is strongly encouraged. A primary goal of the FOA is to identify principles that would inform practice. Applicants should discuss how recommendations based on results of the proposed research could be used to modify and/or reinforce existing practices, and/or inform novel interventions.

To be considered responsive to this FOA, applicants must incorporate all of the following elements into the proposed research plan:

• sound and explicit theoretical basis for the hypothesis to be tested;
• appreciation of the unique socio-cultural qualities and issues of the student population(s) selected for study;
• explicitly identified assumptions underlying intervention designs to be studied by the proposed research, if appropriate;
• description of appropriate comparison or control group(s), if appropriate;
• description of data analysis methodology, including sample size, power and statistics for quantitative studies;
• adequacy of sample size, population size, and analytical methods for qualitative studies; and
• expected outcomes and/or lessons to be learned. NIGMS strongly encourages a collaborative effort, when necessary, among biomedical researchers, program administrators, educators, psychologists, sociologists, biostatisticians, and/or economists, etc., as appropriate, who bring complementary and integrated expertise to ensure rigor, validity, generalizability, and integration of the research elements.

Applicants should note that this funding opportunity is not designed to support evaluation of (an) existing program(s). The purpose is to stimulate research on the underlying assumptions or hypotheses upon which they are built. If development of a database that is designed to address specific research questions is proposed, the rationale for selection of the specific elements must be explained and strongly justified. Similarly, if meta-analysis of available literature is proposed, the need for such an analysis must be explained and strongly justified.

It is expected that the research findings will be published in peer-reviewed journals.

Special Requirements Awardees are also required to attend the annual progress report meeting for the Interventions grantees. These meetings feature presentations by each grantee on the progress made on his/her project during the current reporting period and discussions. Travel costs associated with the annual progress report meeting may be requested in the budget.

See Section VIII, Other Information - Required Federal Citations, for policies related to this announcement.

Funding Instrument	Grant
Application Types Allowed	New Renewals Resubmissions of applications originally submitted to RFA-GM-10-008 or RFA-GM-11-004 The OER Glossary and the SF 424 (R&R) Application Guide provide details on these application types.
Funds Available and Anticipated Number of Awards	NIGMS intends to commit $2,400,000 (total costs) in FY 2012.
Award Budget	Direct costs are limited to no more than $250,000 per year.
Award Project Period	The total project period for an application submitted in response to this funding opportunity may not exceed four years.

NIH grants policies as described in the NIH Grants Policy Statement will apply to the applications submitted and awards made in response to this FOA.

Higher Education Institutions:

• Public/State Controlled Institutions of Higher Education
• Private Institutions of Higher Education

The following types of Higher Education Institutions are always encouraged to apply for NIH support as Public or Private Institutions of Higher Education:

• Hispanic-serving Institutions
• Historically Black Colleges and Universities (HBCUs)
• Tribally Controlled Colleges and Universities (TCCUs)
• Alaska Native and Native Hawaiian Serving Institutions

Nonprofits Other Than Institutions of Higher Education

• Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
• Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

For profit Organizations

• Small Businesses
• For-Profit Organizations (Other than Small Businesses)

Governments

• State Governments
• County Governments
• City or Township Governments
• Special District Governments
• Indian/Native American Tribal Governments (Federally Recognized)
• Indian/Native American Tribal Governments (Other than Federally Recognized)
• Eligible Agencies of the Federal Government
• U.S. Territory or Possession

Other

• Independent School Districts
• Public Housing Authorities/Indian Housing Authorities
• Native American tribal organizations (other than Federally recognized tribal governments)
• Faith-based or Community-based Organizations
• Regional Organizations

Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.

Foreign components, as defined in the NIH Grants Policy Statement, are allowed

Applicant organizations must complete the following registrations as described in the SF 424 (R&R) Application Guide to be eligible to apply for or receive an award. Applicants must have a valid Dun and Bradstreet Universal Numbering System (DUNS) number in order to begin each of the following registrations.

• Central Contractor Registration (CCR) must maintain an active registration, to be renewed at least annually
• Grants.gov
• eRA Commons

All Program Directors/Principal Investigators (PD/PIs) must also work with their institutional officials to register with the eRA Commons or ensure their existing eRA Commons account is affiliated with the eRA Commons account of the applicant organization.

All registrations must be completed by the application due date. Applicant organizations are strongly encouraged to start the registration process at least four (4) weeks prior to the application due date.

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director/Principal Investigator (PD/PI) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.

For institutions/organizations proposing multiple PDs/PIs, visit the Multiple Program Director/Principal Investigator Policy and submission details in the Senior/Key Person Profile (Expanded) Component of the SF 424 (R&R) Application Guide.

This FOA does not require cost sharing as defined in the NIH Grants Policy Statement.

Applicant organizations may submit more than one application, provided that each application is scientifically distinct.

NIH will not accept any application in response to this FOA that is essentially the same as one currently pending initial peer review unless the applicant withdraws the pending application. NIH will not accept any application that is essentially the same as one already reviewed. Resubmission applications may be submitted, according to the NIH Policy on Resubmission Applications from the SF 424 (R&R) Application Guide.

Applicants must download the SF424 (R&R) application package associated with this funding opportunity using the Apply for Grant Electronically button in this FOA or following the directions provided at Grants.gov.

It is critical that applicants follow the instructions in the SF424 (R&R) Application Guide, except where instructed in this funding opportunity announcement to do otherwise. Conformance to the requirements in the Application Guide is required and strictly enforced. Applications that are out of compliance with these instructions may be delayed or not accepted for review.

Although a letter of intent is not required, is not binding, and does not enter into the review of a subsequent application, the information that it contains allows IC staff to estimate the potential review workload and plan the review.

By the date listed in Part 1. Overview Information, prospective applicants are asked to submit a letter of intent that includes the following information:

Descriptive title of proposed research
Name, address, and telephone number of the PD(s)/PI(s)
Names of other key personnel
Participating institutions
Number and title of this funding opportunity

The letter of intent should be sent to:

Clifton A. Poodry, Ph.D.
Director, Minority Opportunities in Research Division
National Institute of General Medical Sciences, NIH
Building 45, Room 2As.37
45 Center Drive, MSC 6200
Bethesda, MD 20892--6200
Telephone: (301) 594-3900
Fax: (301) 480-2753
Email: [email protected]

The forms package associated with this FOA includes all applicable components, mandatory and optional. Please note that some components marked optional in the application package are required for application submission. Follow all instructions in the SF424 (R&R) Application Guide to ensure you complete all appropriate optional components.

All page limitations described in the SF424 Application Guide and the Table of Page Limits must be followed.

All instructions in the SF424 (R&R) Application Guide must be followed, with the following additional instructions:

Resource Sharing Plan

Individuals are required to comply with the instructions for the Resource Sharing Plans (Data Sharing Plan, Sharing Model Organisms, and Genome Wide Association Studies (GWAS)) as provided in the SF424 (R&R) Application Guide, with the following modifications:

• Generally, Resource Sharing Plans (Data Sharing Plan, Sharing Model Organisms, and GWAS Sharing Plan) are expected, but they are not applicable for this FOA.

Appendix

Do not use the appendix to circumvent page limits. Follow all instructions for the Appendix as described in the SF424 (R&R) Application Guide.

Foreign (non-US) organizations must follow policies described in the NIH Grants Policy Statement, and procedures for foreign organizations described throughout the SF424 (R&R) Application Guide.

Part I. Overview Information contains information about Key Dates. Applicants are encouraged to submit in advance of the deadline to ensure they have time to make any application corrections that might be necessary for successful submission.

Organizations must submit applications via Grants.gov, the online portal to find and apply for grants across all Federal agencies. Applicants must then complete the submission process by tracking the status of the application in the eRA Commons, NIH’s electronic system for grants administration.

Applicants are responsible for viewing their application in the eRA Commons to ensure accurate and successful submission.

Information on the submission process and a definition of on-time submission are provided in the SF424 (R&R) Application Guide.

This initiative is not subject to intergovernmental review.

All NIH awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Pre-award costs are allowable only as described in the NIH Grants Policy Statement.

Applications must be submitted electronically following the instructions described in the SF 424 (R&R) Application Guide. Paper applications will not be accepted.

Applicants must complete all required registrations before the application due date. Section III. Eligibility Information contains information about registration.

For assistance with your electronic application or for more information on the electronic submission process, visit Applying Electronically.

Important reminders:
All PD/PIs must include their eRA Commons ID in the Credential field of the Senior/Key Person Profile Component of the SF 424(R&R) Application Package. Failure to register in the Commons and to include a valid PD/PI Commons ID in the credential field will prevent the successful submission of an electronic application to NIH.

The applicant organization must ensure that the DUNS number it provides on the application is the same number used in the organization’s profile in the eRA Commons and for the Central Contractor Registration (CCR). Additional information may be found in the SF424 (R&R) Application Guide.

See more tips for avoiding common errors.

Upon receipt, applications will be evaluated for completeness by the Center for Scientific Review and responsiveness by the National Institute of General Medical Sciences, NIH. Applications that are incomplete and/or nonresponsive will not be reviewed.

Applicants are required to follow the instructions for post-submission materials, as described in NOT-OD-10-115.

Only the review criteria described below will be considered in the review process. As part of the NIH mission, all applications submitted to the NIH in support of biomedical and behavioral research are evaluated for scientific and technical merit through the NIH peer review system.

Reviewers will provide an overall impact/priority score to reflect their assessment of the likelihood for the project to exert a sustained, powerful influence on the research field(s) involved, in consideration of the following review criteria and additional review criteria (as applicable for the project proposed).

Reviewers will consider each of the review criteria below in the determination of scientific merit, and give a separate score for each. An application does not need to be strong in all categories to be judged likely to have major scientific impact. For example, a project that by its nature is not innovative may be essential to advance a field.

Significance

Does the project address an important problem or a critical barrier to progress in the field? If the aims of the project are achieved, how will scientific knowledge, technical capability, and/or clinical practice be improved? How will successful completion of the aims change the concepts, methods, technologies, treatments, services, or preventative interventions that drive this field?

Investigator(s)

Are the PD/PIs, collaborators, and other researchers well suited to the project? If Early Stage Investigators or New Investigators, or in the early stages of independent careers, do they have appropriate experience and training? If established, have they demonstrated an ongoing record of accomplishments that have advanced their field(s)? If the project is collaborative or multi-PD/PI, do the investigators have complementary and integrated expertise; are their leadership approach, governance and organizational structure appropriate for the project?

Innovation

Does the application challenge and seek to shift current research or clinical practice paradigms by utilizing novel theoretical concepts, approaches or methodologies, instrumentation, or interventions? Are the concepts, approaches or methodologies, instrumentation, or interventions novel to one field of research or novel in a broad sense? Is a refinement, improvement, or new application of theoretical concepts, approaches or methodologies, instrumentation, or interventions proposed?

Approach

Are the overall strategy, methodology, and analyses well-reasoned and appropriate to accomplish the specific aims of the project? Are potential problems, alternative strategies, and benchmarks for success presented? If the project is in the early stages of development, will the strategy establish feasibility and will particularly risky aspects be managed?

If the project involves clinical research, are the plans for 1) protection of human subjects from research risks, and 2) inclusion of minorities and members of both sexes/genders, as well as the inclusion of children, justified in terms of the scientific goals and research strategy proposed?

Environment

Will the scientific environment in which the work will be done contribute to the probability of success? Are the institutional support, equipment and other physical resources available to the investigators adequate for the project proposed? Will the project benefit from unique features of the scientific environment, subject populations, or collaborative arrangements?

As applicable for the project proposed, reviewers will evaluate the following additional items while determining scientific and technical merit, and in providing an overall impact/priority score, but will not give separate scores for these items.

Protections for Human Subjects

For research that involves human subjects but does not involve one of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate the justification for involvement of human subjects and the proposed protections from research risk relating to their participation according to the following five review criteria: 1) risk to subjects, 2) adequacy of protection against risks, 3) potential benefits to the subjects and others, 4) importance of the knowledge to be gained, and 5) data and safety monitoring for clinical trials.

For research that involves human subjects and meets the criteria for one or more of the six categories of research that are exempt under 45 CFR Part 46, the committee will evaluate: 1) the justification for the exemption, 2) human subjects involvement and characteristics, and 3) sources of materials. For additional information on review of the Human Subjects section, please refer to the Human Subjects Protection and Inclusion Guidelines.

Inclusion of Women, Minorities, and Children

When the proposed project involves clinical research, the committee will evaluate the proposed plans for inclusion of minorities and members of both genders, as well as the inclusion of children. For additional information on review of the Inclusion section, please refer to the Human Subjects Protection and Inclusion Guidelines.

Vertebrate Animals

The committee will evaluate the involvement of live vertebrate animals as part of the scientific assessment according to the following five points: 1) proposed use of the animals, and species, strains, ages, sex, and numbers to be used; 2) justifications for the use of animals and for the appropriateness of the species and numbers proposed; 3) adequacy of veterinary care; 4) procedures for limiting discomfort, distress, pain and injury to that which is unavoidable in the conduct of scientifically sound research including the use of analgesic, anesthetic, and tranquilizing drugs and/or comfortable restraining devices; and 5) methods of euthanasia and reason for selection if not consistent with the AVMA Guidelines on Euthanasia. For additional information on review of the Vertebrate Animals section, please refer to the Worksheet for Review of the Vertebrate Animal Section.

Biohazards

Reviewers will assess whether materials or procedures proposed are potentially hazardous to research personnel and/or the environment, and if needed, determine whether adequate protection is proposed.

Resubmissions

For Resubmissions, the committee will evaluate the application as now presented, taking into consideration the responses to comments from the previous scientific review group and changes made to the project.

Renewals

For Renewals, the committee will consider the progress made in the last funding period.

Revisions

Not Applicable

As applicable for the project proposed, reviewers will consider each of the following items, but will not give scores for these items, and should not consider them in providing an overall impact/priority score.

Applications from Foreign Organizations

Reviewers will assess whether the project presents special opportunities for furthering research programs through the use of unusual talent, resources, populations, or environmental conditions that exist in other countries and either are not readily available in the United States or augment existing U.S. resources.

Select Agent Research

Reviewers will assess the information provided in this section of the application, including 1) the Select Agent(s) to be used in the proposed research, 2) the registration status of all entities where Select Agent(s) will be used, 3) the procedures that will be used to monitor possession use and transfer of Select Agent(s), and 4) plans for appropriate biosafety, biocontainment, and security of the Select Agent(s).

Resource Sharing Plans

Reviewers will comment on whether the following Resource Sharing Plans, or the rationale for not sharing the following types of resources, are reasonable: 1) Data Sharing Plan; 2) Sharing Model Organisms; and 3) Genome Wide Association Studies (GWAS).

Budget and Period of Support

Reviewers will consider whether the budget and the requested period of support are fully justified and reasonable in relation to the proposed research.

Applications will be evaluated for scientific and technical merit by (an) appropriate Scientific Review Group(s) convened by NIGMS, in accordance with NIH peer review policy and procedures, using the stated review criteria. Review assignments will be shown in the eRA Commons.

As part of the scientific peer review, all applications:

• May undergo a selection process in which only those applications deemed to have the highest scientific and technical merit (generally the top half of applications under review), will be discussed and assigned an overall impact/priority score.
• Will receive a written critique.

Applications will compete for available funds with all other recommended applications submitted in response to this FOA. Following initial peer review, recommended applications will receive a second level of review by the National Advisory General Medical Sciences Council. The following will be considered in making funding decisions:

• Scientific and technical merit of the proposed project as determined by scientific peer review.
• Availability of funds.
• Relevance of the proposed project to program priorities.

After the peer review of the application is completed, the PD/PI will be able to access his or her Summary Statement (written critique) via the eRA Commons.

Information regarding the disposition of applications is available in the NIH Grants Policy Statement.

If the application is under consideration for funding, NIH will request "just-in-time" information from the applicant as described in the NIH Grants Policy Statement.

A formal notification in the form of a Notice of Award (NoA) will be provided to the applicant organization for successful applications. The NoA signed by the grants management officer is the authorizing document and will be sent via email to the grantee business official.

Awardees must comply with any funding restrictions described in Section IV.5. Funding Restrictions. Selection of an application for award is not an authorization to begin performance. Any costs incurred before receipt of the NoA are at the recipient's risk. These costs may be reimbursed only to the extent considered allowable pre-award costs.

Any application awarded in response to this FOA will be subject to the DUNS, CCR Registration, and Transparency Act requirements as noted on the Award Conditions and Information for NIH Grants website.

All NIH grant and cooperative agreement awards include the NIH Grants Policy Statement as part of the NoA. For these terms of award, see the NIH Grants Policy Statement Part II: Terms and Conditions of NIH Grant Awards, Subpart A: General and Part II: Terms and Conditions of NIH Grant Awards, Subpart B: Terms and Conditions for Specific Types of Grants, Grantees, and Activities. More information is provided at Award Conditions and Information for NIH Grants.

Cooperative Agreement Terms and Conditions of Award

Not Applicable.

When multiple years are involved, awardees will be required to submit the Non-Competing Continuation Grant Progress Report (PHS 2590) annually and financial statements as required in the NIH Grants Policy Statement.

A final progress report, invention statement, and the expenditure data portion of the Federal Financial Report are required for closeout of an award, as described in the NIH Grants Policy Statement.

The Federal Funding Accountability and Transparency Act of 2006 (Transparency Act), includes a requirement for awardees of Federal grants to report information about first-tier subawards and executive compensation under Federal assistance awards issued in FY2011 or later. All awardees of applicable NIH grants and cooperative agreements are required to report to the Federal Subaward Reporting System (FSRS) available at www.fsrs.gov on all subawards over $25,000. See the NIH Grants Policy Statement for additional information on this reporting requirement.

We encourage inquiries concerning this funding opportunity and welcome the opportunity to answer questions from potential applicants.

Grants.gov Customer Support (Questions regarding Grants.gov registration and submission, downloading or navigating forms)
Contact Center Phone: 800-518-4726
Email: [email protected]

GrantsInfo (Questions regarding application instructions and process, finding NIH grant resources)
Telephone 301-710-0267
TTY 301-451-5936
Email: [email protected]

eRA Commons Help Desk(Questions regarding eRA Commons registration, tracking application status, post submission issues)
Phone: 301-402-7469 or 866-504-9552 (Toll Free)
TTY: 301-451-5939
Email: [email protected]

Clifton A. Poodry, Ph.D.
Director, Minority Opportunities in Research Division
National Institute of General Medical Sciences, NIH
Building 45, Room 2As.37
45 Center Drive, MSC 6200
Bethesda, MD 20892--6200
Telephone: (301) 594-3900
Fax: (301) 480-2753
Email: [email protected]

Helen R. Sunshine, Ph.D.
Chief, Office of Scientific Review
National Institute of General Medical Sciences, NIH
Building 45, Room 3AN.12
45 Center Drive, MSC 6200
Bethesda, MD 20892-6200
Telephone: (301) 594-2881
Fax: (301) 480-8506
Email: [email protected].

Ms. Lori Burge
Grants Management Officer
National Institute of General Medical Sciences, NIH
Building 45, Room 2AN.50A
45 Center Drive, MSC 6200
Bethesda, MD 20892-6200
Telephone: (301) 451-3781
Fax: (301) 480-2554
Email: [email protected]

Recently issued trans-NIH policy notices may affect your application submission. A full list of policy notices published by NIH is provided in the NIH Guide for Grants and Contracts. All awards are subject to the terms and conditions, cost principles, and other considerations described in the NIH Grants Policy Statement.

Awards are made under the authorization of Sections 301 and 405 of the Public Health Service Act as amended (42 USC 241 and 284) and under Federal Regulations 42 CFR Part 52 and 45 CFR Parts 74 and 92.